Common Heartburn Drug Class Linked to Kidney Disease

Common Heartburn Drug Class Linked to Kidney Disease

Proton pump inhibitors are quickly becoming
the treatment of choice for people suffering with heartburn and acid reflux, but could
patients be unknowingly putting themselves at risk for serious complications? I’m Rachelle
Grossman with your latest health news. Two new studies found that proton pump inhibitors,
or PPI’s may increase the risk of chronic kidney disease. PPIs are a class of drugs
sold under the brand names Prilosec, Nexium, and Prevacid, among others. The lead study
author says as the popularity of these drugs increases, health care providers need to be
better educated about the potential side effects of these drugs. Chronic Kidney Disease is
a condition characterized by a gradual loss of kidney function over time. It can eventually
progress to end-stage kidney failure, which is fatal without dialysis or a kidney transplant.
The teams of researchers looked at thousands of US adults with normal kidney function.
They found that the patients who took PPIs were more likely to develop Chronic Kidney
Disease compared to those who didn’t take the drugs. However, it is important to note
that PPIs were also linked to a reduced risk of vascular disease, cancer, diabetes, high
blood pressure and COPD. Speak with your doctor if you take PPI’s and have any concerns.

One thought on “Common Heartburn Drug Class Linked to Kidney Disease

  1. My medical professionsal figured out that I have a huge swelling within my esophagus as well as chronic acid reflux disease. Luckily, I had been helped with this acid reflux disorder solution “Dοcuzu Rαkα” (Gοοgle it). After 14 days of utilizing this treatment plan, the acid reflux and also the acid I usually felt within my mouth are completely gone. .

Leave a Reply

Your email address will not be published. Required fields are marked *